Rodman & Renshaw Starts ARIAD Pharmaceuticals (ARIA) at Market Outperform
Tweet
Share
E-mailGet Alerts ARIA Hot Sheet
Price: $25.78 -0.96%
Rating Summary:
10 Buy, 12 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
10 Buy, 12 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Rodman & Renshaw initiates coverage on ARIAD Pharmaceuticals (NASDAQ: ARIA) with a Market Outperform. PT $15.00.
For more ratings news on ARIAD Pharmaceuticals click here and for the rating history of ARIAD Pharmaceuticals click here.
Shares of ARIAD Pharmaceuticals closed at $9.94 yesterday.
For more ratings news on ARIAD Pharmaceuticals click here and for the rating history of ARIAD Pharmaceuticals click here.
Shares of ARIAD Pharmaceuticals closed at $9.94 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Exchange Traded Concepts and ARIAM Global launch ARIA an Actively Managed ETF Led by a Portfolio Manager with a Ph.D. in AI and Computer Science
- Raymond James Starts SpyGlass Pharma (SGP) at Outperform
- Leerink Starts Freenome Inc. (FRNM) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Rodman & RenshawSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
